High risk of hypogonadism in young male cancer survivors

Cancer and its treatment in childhood and young adulthood can cause hypogonadism, leading to increased risk of long term morbidity and mortality. The aim of this study was to evaluate the risk of presenting with biochemical signs of hypogonadism in testicular cancer survivors and male childhood cancer survivors in relation to the type of treatment given.
Uro Today